RIOX2 and metastatic malignant neoplasm in the lymph nodes: This observation is in agreement with our studies regarding the prognostic value of mdig/MINA for breast cancer patients, in which an increased expression of mdig/MINA predicted poorer OS of the patients who have no lymph node metastasis but better OS of the ones who have signs of lymph node metastasis [24].